Valuation (72%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 19.20 | N/A |
| PEG Ratio (TTM) | -1.05 | N/A |
| P/S Ratio (TTM) | 1.10 | N/A |
| P/B Ratio (TTM) | 1.48 | N/A |
| P/FCF Ratio (TTM) | 14.61 | N/A |
| Price to 5YR AVG Earnings Ratio | 15.42 | N/A |
| Price to 5YR AVG FCF Ratio | 35.96 | N/A |
Profitability (40%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 5.57% | N/A |
| ROE (TTM) | 7.88% | N/A |
| Net Profit Margin (TTM) | 5.76% | N/A |
| ROIC 5YR AVG | 13.35% | N/A |
Growth (62%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -6.91% | 12.90% | 21.38% |
| Revenue | -2.02% | 7.16% | 9.94% |
| Net Income | -6.75% | 11.82% | 20.82% |
| Cash Flow | 50.03% | 17.38% | 68.31% |
Health (89%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.81 | N/A |
| Quick Ratio (TTM) | 1.56 | N/A |
| D/E Ratio (TTM) | 0.08 | N/A |
| Interest Coverage (TTM) | 15.78 | N/A |
| Piotroski F-Score | 8 | N/A |
| Altman Z-Score | 5.24 | N/A |
| LTL to 5YR AVG FCF | 3.22 | N/A |
| Shares Outstanding Growth 5YR AVG | -0.45% | N/A |